Skorpios Trust

SEC CIK: 0001869333

SEC filings (opens in a new tab)

No open-market purchases or sales filed in the past year.

Current role at each company

STOK Stoke Therapeutics, Inc.10% Owneras of Jun 6, 2025
AKRO Akero Therapeutics, Inc.Other: Former 10% owneras of Dec 5, 2022

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: –; 0 filings
Net: –; Bought minus sold
Companies: 0; With open-market trades

Trades

Every Form 4 that lists Skorpios Trust as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

STOK Stoke Therapeutics, Inc.

10% Owner4 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change
Jun 6, 2025 (view filing)4:20 PM ET	Jun 4	2 days	Ezbon International Ltd and 3 others10% Owner	SSale	−3.00M	$10.20	−$30.6M	−43.4%3.91M after
Dec 27, 2024 (view filing)5:13 PM ET	Dec 23	4 days	Ezbon International Ltd and 3 others10% Owner	SSale	−2.00M	$11.50	−$23.0M	−22.5%6.91M after
Sep 23, 2024 (view filing)4:23 PM ET	Sep 19	4 days	Ezbon International Ltd and 3 others10% Owner	SSale	−1.94M	$14.05	−$27.2M	−17.9%8.91M after
Apr 18, 2024 (view filing)4:16 PM ET	Apr 17	1 day	Ezbon International Ltd and 3 others10% Owner	SSale	−3.60M	$11.60	−$41.8M	−24.9%10.8M after

AKRO Akero Therapeutics, Inc.

Other: Former 10% owner1 trade

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Dec 5, 2022 (view filing)4:36 PM ET	Dec 1	4 days	Ezbon International Ltd and 3 othersOther: Former 10% owner	SSale	−1.64M	$43.50	−$71.2M	−33.3%3.27M after